CPHI vs PHM · rev $4.1M vs P/E 7.7, rev $17.95B
China Pharma Holdings Inc (CPHI) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
CPHI currently screens at market cap $29.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the CPHI and PHM stock pages for the full models.
Not investment advice.